There was no significant change in CD4 T cell abundance observed across conditions (Figure 2I), yet an increase in the number of CD8+ T cells within the tumor T cell population of drug resistant primary tumors, compared to the drug-sensitive tumors (58.1%, 47.8% respectively) was observed (Figure 2J). The gene discussed is CD8A; the disease is neoplasm.